A time course study indicated that MDV3100 (MDV), an androgen receptor antagonist, induced protein carbonyls in a time-dependent manner starting from 3 h post treatment, and that CIS-induced protein carbonyls reached the maximum at 1 h post treatment and maintained saturated at later time points (Fig. 1f). The gene discussed is AR; the disease is in situ carcinoma.